Guided Therapeutics (GTHP) Current Assets (2010 - 2025)
Guided Therapeutics recorded quarterly Current Assets of $605000.0 in Q4 2025, down 24.28% quarter-over-quarter from $799000.0 in Q3 2025, and down 49.46% year-over-year from $1.2 million in Q4 2024.
Guided Therapeutics' Current Assets history runs 16 years deep, the most recent figure standing at $605000.0 for Q4 2025.
- In Q4 2025, Current Assets fell 49.46% year-over-year to $605000.0; the TTM figure through Dec 2025 stood at $605000.0 (down 49.46% YoY), while the FY2025 annual figure was $605000.0, down 49.46% from the prior year.
- Current Assets came in at $605000.0 for Q4 2025 at Guided Therapeutics, down from $799000.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $3.5 million in Q3 2022 to a low of $605000.0 in Q4 2025.
- A 5-year average of $1.5 million and a median of $1.4 million in 2021 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 705.04% in 2021 and tumbled 54.8% in 2023, its largest moves.
- Guided Therapeutics' Current Assets stood at $1.6 million in 2021, then surged by 83.51% to $3.0 million in 2022, then plunged by 53.63% to $1.4 million in 2023, then declined by 14.07% to $1.2 million in 2024, then slumped by 49.46% to $605000.0 in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $605000.0, $799000.0, and $811000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.45 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 4.33 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.39 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 605,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 799,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 811,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 1.64 Mn |
| Mar 31, 2021 | 1.92 Mn |
| Dec 31, 2020 | 896,000.00 |
| Sep 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 855,000.00 |
| Mar 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 1.03 Mn |
| Sep 30, 2019 | 168,000.00 |
| Jun 30, 2019 | 66,000.00 |
| Mar 31, 2019 | 167,000.00 |
| Dec 31, 2018 | 196,000.00 |
| Sep 30, 2018 | 447,000.00 |
| Jun 30, 2018 | 368,000.00 |
| Mar 31, 2018 | 466,000.00 |
| Dec 31, 2017 | 297,000.00 |
| Sep 30, 2017 | 830,000.00 |
| Jun 30, 2017 | 1.12 Mn |
| Mar 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | 1.05 Mn |
| Sep 30, 2016 | 1.86 Mn |
| Jun 30, 2016 | 2.05 Mn |
| Mar 31, 2016 | 2.05 Mn |
| Dec 31, 2015 | 2.12 Mn |
| Sep 30, 2015 | 2.28 Mn |
| Jun 30, 2015 | 3.27 Mn |
| Mar 31, 2015 | 1.58 Mn |
| Dec 31, 2014 | 1.78 Mn |
| Sep 30, 2014 | 2.09 Mn |
| Jun 30, 2014 | 1.85 Mn |
| Mar 31, 2014 | 1.47 Mn |
| Dec 31, 2013 | 2.04 Mn |
| Sep 30, 2013 | 1.51 Mn |
| Jun 30, 2013 | 2.88 Mn |
| Mar 31, 2013 | 1.96 Mn |
| Dec 31, 2012 | 1.87 Mn |
| Sep 30, 2012 | 3.25 Mn |
| Jun 30, 2012 | 2.08 Mn |
| Mar 31, 2012 | 1.70 Mn |
| Dec 31, 2011 | 2.89 Mn |
| Jun 30, 2011 | 2.51 Mn |
| Dec 31, 2010 | 3.38 Mn |